26 studies found for:    "Congenital cytomegalovirus"
Show Display Options
Rank Status Study
1 Terminated Congenital Cytomegalovirus: Efficacy of Antiviral Treatment in a Randomized Controlled Trial
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
2 Recruiting Congenital Cytomegalovirus: Efficacy of Antiviral Treatment
Conditions: Congenital Cytomegalovirus Infection;   Sensorineural Hearing Loss
Intervention: Drug: Valganciclovir
3 Recruiting A Randomized Trial to Prevent Congenital Cytomegalovirus (CMV)
Conditions: Congenital Cytomegalovirus Infection;   Maternal Cytomegalovirus Infection
Intervention: Drug: CMV hyperimmune globulin
4 Recruiting Diagnosis of Congenital CMV Infection in Neonates Who Failed Newborn Hearing Screening
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: CMV PCR
5 Recruiting Congenital CMV and Hearing Loss in Children up to 4 Years of Age: Treating With Valganciclovir Therapy
Conditions: Congenital Cytomegalovirus;   Hearing Loss
Interventions: Drug: Valcyte (Valganciclovir hydrochloride) Powder for oral solution;   Drug: Placebo
6 Recruiting Assesment of Olfactory Disorders and Performance of a New Olfactory Test in Children With Congenital CMV
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: olfactory tests, otoacoustic emissions (OAE)
7 Not yet recruiting Evaluation of the Benefit of Antiviral Treatment With Valganciclovir on Congenital CMV Infection-related Deafness on Hearing and Balance
Condition: Congenital Cytomegalovirus (CMV)
Intervention: Drug: Valganciclovir
8 Recruiting A Cross-sectional Study of Congenital Cytomegalovirus Infection in Newborns in China
Condition: Congenital Cytomegalovirus Infection
Intervention:
9 Recruiting Valacyclovir to Prevent Vertical Transmission of Cytomegalovirus After Maternal Primary Infection During Pregnancy
Condition: Congenital Cytomegalovirus Infection
Interventions: Drug: Valacyclovir;   Drug: Placebo
10 Completed Valganciclovir in Congenital CMV Infants
Condition: Cytomegalovirus Infections
Interventions: Drug: Valganciclovir;   Drug: Ganciclovir
11 Recruiting A Cohort Study of Cytomegalovirus(CMV) Infection Among Pregnant Women and Their Newborns in China
Conditions: Congenital Cytomegalovirus Infection;   Cytomegalovirus Infection Reactivation
Intervention:
12 Withdrawn Safety, Tolerability, and Immunogenicity of a Cytomegalovirus DNA Vaccine
Condition: Congenital Cytomegalovirus Infection
Intervention: Drug: CyMVectin
13 Recruiting Prognostic Value of Neonatal Markers (Clinical, Imaging and Biological) for the Development of Neurosensorial Sequelae in Children Infected by Cytomegalovirus (CMV) in Utero
Condition: Congenital Cytomegalovirus Infection
Intervention: Other: Standardized test report
14 Enrolling by invitation Screening for Congenital Cytomegalovirus Infection in Newborns
Condition: Cytomegalovirus Infections
Intervention: Other: Observation
15 Not yet recruiting Myocardial Screening in Fetuses With Congenital Cytomegalovirus (CMV) Infection
Condition: Disorder of Cardiac Function
Intervention: Device: echocardiographic examination
16 Completed A Phase III Study to Evaluate the Safety and Efficacy of Ganciclovir (Dihydroxypropoxymethyl Guanine [DHPG]) Treatment of Symptomatic Central Nervous System (CNS) Congenital Cytomegalovirus (CMV) Infections.
Condition: Cytomegalovirus Infections
Intervention: Drug: ganciclovir
17 Completed Phase I/II Study of Human Anti-Cytomegalovirus (CMV) Monoclonal Antibody MSL-109 in Newborns With Symptomatic Congenital CMV Infection Without Central Nervous System Disease
Condition: Cytomegalovirus Infections
Intervention: Drug: SDZ MSL-109
18 Unknown  Evaluation of the Safety and Efficacy of Standard Intravenous Immunoglobulins in Pregnant Women With Primary Cytomegalovirus Infection
Condition: Cytomegalovirus Congenital Infection
Intervention: Biological: standard intravenous immunoglobulin
19 Completed
Has Results
Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
Condition: Cytomegalovirus Infection
Interventions: Other: Placebo;   Drug: Valganciclovir
20 Completed Phase III Randomized, Controlled Study of Ganciclovir for Symptomatic Congenital Cytomegalovirus Infection
Condition: Cytomegalovirus Infections
Intervention: Drug: ganciclovir

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years